Potent immunosuppressive activity of a phosphodiesterase‐4 inhibitor N‐acylhydrazone in models of lipopolysaccharide‐induced shock and delayed‐type hypersensitivity reaction

[1]  S. Lata,et al.  Role of IL‐1&bgr;, IL‐6 and TNF‐&agr; cytokines and TNF‐&agr; promoter variability in Plasmodium vivax infection during pregnancy in endemic population of Jharkhand, India , 2018, Molecular immunology.

[2]  L. Dardenne,et al.  Discovery of naphthyl‐N‐acylhydrazone p38α MAPK inhibitors with in vivo anti‐inflammatory and anti‐TNF‐α activity , 2018, Chemical biology & drug design.

[3]  Hong-min Liu,et al.  Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation. , 2017, Bioorganic & medicinal chemistry letters.

[4]  Wei-Chung Cheng,et al.  Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response , 2017, Scientific Reports.

[5]  T. Vilsbøll,et al.  Efficacy and safety of fixed-ratio combination of insulin degludec and liraglutide (IDegLira) for the treatment of type 2 diabetes , 2017, Expert opinion on drug safety.

[6]  J. Wolfender,et al.  Conjugation of N-acylhydrazone and 1,2,4-oxadiazole leads to the identification of active antimalarial agents. , 2016, Bioorganic & medicinal chemistry.

[7]  C. A. Fraga,et al.  Discovery of Novel Orally Active Tetrahydro-Naphthyl-N-Acylhydrazones with In Vivo Anti-TNF-α Effect and Remarkable Anti-Inflammatory Properties , 2016, PloS one.

[8]  D. A. Rodrigues,et al.  Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors. , 2016, Journal of medicinal chemistry.

[9]  A. Donato,et al.  Cellular and molecular biology of aging endothelial cells. , 2015, Journal of molecular and cellular cardiology.

[10]  Hikmat N. Daghestani,et al.  N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia. , 2015, European journal of medicinal chemistry.

[11]  Snehal S. Patel,et al.  An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance , 2015, Journal of complementary & integrative medicine.

[12]  M. S. Alexandre-Moreira,et al.  Novel Orally Active Analgesic and Anti-Inflammatory Cyclohexyl-N-Acylhydrazone Derivatives , 2015, Molecules.

[13]  C. Fraga,et al.  Antiprotozoal Activity of (E)-Cinnamic N-Acylhydrazone Derivatives , 2014, Molecules.

[14]  K. Walsh,et al.  The Good, the Bad, and the Ugly of interleukin‐6 signaling , 2014, The EMBO journal.

[15]  L. M. Lima,et al.  N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity. , 2014, International journal of cardiology.

[16]  L. M. Lima,et al.  Docking, Synthesis and Antiproliferative Activity of N-Acylhydrazone Derivatives Designed as Combretastatin A4 Analogues , 2014, PloS one.

[17]  A. Ballester,et al.  Comparative assessment of PDE 4 and 7 inhibitors as therapeutic agents in experimental autoimmune encephalomyelitis , 2013, British journal of pharmacology.

[18]  J. Bourguignon,et al.  Design, synthesis, and pharmacological evaluation of N-acylhydrazones and novel conformationally constrained compounds as selective and potent orally active phosphodiesterase-4 inhibitors. , 2012, Journal of medicinal chemistry.

[19]  B. Narasimhan,et al.  Nicotinic Acid Benzylidene/Phenyl-Ethylidene Hydrazides: Synthesis, Antimicrobial Evaluation and QSAR Studies , 2011 .

[20]  Ming Yang,et al.  Synthesis and Antiviral Evaluation of New N‐acylhydrazones Containing Glycine Residue , 2011, Chemical biology & drug design.

[21]  M. Simon,et al.  Suppression of LPS-Induced TNF-α Production in Macrophages by cAMP Is Mediated by PKA-AKAP95-p105 , 2009, Science Signaling.

[22]  J. Ellena,et al.  Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: orally effective anti-inflammatory drug candidates. , 2009, Bioorganic & medicinal chemistry.

[23]  Eliezer J Barreiro,et al.  Privileged structures: a useful concept for the rational design of new lead drug candidates. , 2007, Mini reviews in medicinal chemistry.

[24]  D. Warhurst,et al.  Modified Fixed-Ratio Isobologram Method for Studying In Vitro Interactions between Atovaquone and Proguanil or Dihydroartemisinin against Drug-Resistant Strains of Plasmodium falciparum , 2004, Antimicrobial Agents and Chemotherapy.

[25]  S. Akira,et al.  IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages , 2003, Nature Immunology.

[26]  M. Soares,et al.  The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-alpha and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor. , 1998, Journal of immunology.

[27]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[28]  M. Feldmann,et al.  Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram. , 1997, Journal of immunology.

[29]  C. Dinarello,et al.  Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. , 1997, Chest.

[30]  H. Erdjument-Bromage,et al.  The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.

[31]  D. Yarnall,et al.  Anti‐inflammatory activity of phosphodiesterase (PDE)‐IV inhibitors in acute and chronic models of inflammation , 1995, Clinical and experimental immunology.

[32]  E. F. Smith,et al.  Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. , 1994, International journal of immunopharmacology.

[33]  S. Akira,et al.  Interleukin-6 and its receptor: a paradigm for cytokines. , 1992, Science.

[34]  R. Zitnik,et al.  Cytokine-cytokine interactions in the context of cytokine networking. , 1992, American journal of respiratory cell and molecular biology.

[35]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[36]  R. Titus,et al.  A simple and effective method to assess murine delayed type hypersensitivity to proteins. , 1981, Journal of immunological methods.

[37]  M. Rosenblatt.  Anti-Infective and Anti-Inflammatory Pharmacotherapies. , 2017, Handbook of experimental pharmacology.

[38]  L. Dardenne,et al.  LASSBio‐1829 Hydrochloride: Development of a New Orally Active N‐Acylhydrazone IKK2 Inhibitor with Anti‐inflammatory Properties , 2016, ChemMedChem.

[39]  L. Partridge,et al.  Interleukin-6 signaling promotes alternative macrophage activation to limit obesity-associated insulin resistance and endotoxemia , 2016 .

[40]  L. M. Lima,et al.  Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates. , 2013, European journal of medicinal chemistry.

[41]  M. Agarwal.  The antiglucocorticoid action of mifepristone. , 1996 .

[42]  V. Kuchroo,et al.  Antigen Specific Suppressor Cells, Receptors, and Factors , 1989 .